Tirzepatide Lyophilized High Purity 99% Peptide Powder TR 10mg 15mg 20mg 30mg ngevial ​​nganye yeswekile yegazi/seswekile

I-Tirzepatide iyiveli ye-glucose exhomekeke kwi-insulinotropic polypeptide / glucagon-like peptide 1 (GLP-1) i-receptor agonist evunyiweyo e-United States njenge-adjunct yokutya kunye nokuzivocavoca ukuphucula ukulawulwa kwe-glycemic kubantu abadala abanesifo seswekile se-2 kwaye phantsi kophando lokusetyenziswa kulawulo lobunzima obungapheliyo, iziganeko ezinkulu ezimbi ze-cardiovascular kunye nokulawulwa kwe-heart fraction kunye nezinye iimeko ezigciniweyo kunye ne-obed non-cirrhotic non-alcoholic steatohepatitis. ISigaba se-3 SURPASS 1-5 inkqubo yovavanyo lwekliniki yenzelwe ukuvavanya ukusebenza kunye nokhuseleko lwe-tirzepatide efakwe kanye ngeveki i-tirzepatide (5, 10 kunye ne-15 mg), njenge-monotherapy okanye unyango oludibeneyo, kwi-spectrum ebanzi yabantu abanesifo sikashukela sohlobo lwe-2. Ukusetyenziswa kwe-tirzepatide kwizifundo zeklinikhi kwayanyaniswa nokuncipha okuphawulweyo kwe-hemoglobin ye-glycated (-1.87 ukuya kwi-2.59%, -20 ukuya kwi-28 mmol / mol) kunye nobunzima bomzimba (-6.2 ukuya kwi-12.9 kg), kunye nokunciphisa iiparitha eziqhelekileyo ezinxulumene nomngcipheko ophezulu we-cardiometabolic ezifana noxinzelelo lwegazi, i-viscerides kunye ne-triglycerides. I-Tirzepatide yayinyamezeleke kakuhle, kunye nomngcipheko ophantsi we-hypoglycaemia xa isetyenziswe ngaphandle kwe-insulin okanye i-insulin secretagogues kwaye ibonise iphrofayili yokhuseleko efana ngokubanzi neklasi ye-GLP-1 ye-receptor agonist. Ngako oko, ubungqina obuvela kolu vavanyo lweklinikhi bubonisa ukuba i-tirzepatide inika ithuba elitsha lokuthoba i-hemoglobin ye-glycated kunye nobunzima bomzimba kubantu abadala abanesifo seswekile se-2.